Tabula Rasa HealthCare, Inc. Common Stock

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 350 points on Monday. The Dow traded up 1.02% to 35,423.19 while the NASDAQ rose 0.24% to 13,942.57. The S&P 500, also rose, gaining, 0.65% to 4,507.13. Check This Out: Merck, Delta Air Lines And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors Financials shares jumped by 1.4% on Monday. In trading on Monday, information technology shares fell 0.1%.   Top Headline Henry Schein Inc (NASDAQ: HSIC) reported better-than-expected second-quarter earnings. Henry Schein posted quarterly sales of $3.10 billion, slightly missing the consensus of $3.11 billion, up 2.3% Y/Y, including 0.2% decrease in local currencies excluding acquisitions, 2.9% growth from acquisitions, and a 0.4% decrease related to foreign currency exchange. Adjusted EPS of $1.31, up 0.8%, beat the estimate of $1.25.   Equities Trading UP Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares shot up 1,026% to $18.91 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints. Shares of Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) got a boost, shooting 31% to $10.26 after the company reported better-than-expected second-quarter financial results. Sequans Communications S.A. (NYSE: SQNS) shares were also ...

Related tickers: HSIC, SQNS, SAGE, TRHC, VTGN, YELL, TIVC.

Nautic Partners agreed to acquire Tabula Rasa HealthCare Inc (NASDAQ: TRHC) for $10.50 in cash per share and combine with ExactCare Pharmacy, a portfolio company of Nautic.  The all-cash transaction values Tabula Rasa at approximately $570 million including net debt of approximately $262 million on an enterprise value basis. Following the closing of the transaction, John Figueroa, ExactCare's current Executive Chairman, will assume the role of Chairman and CEO of the combined company. The transaction is expected to close during Q4 of 2023. The deal expands the reach of Tabula Rasa's MedWise technology platform to multiple provider and payer markets. Tabula Rasa HealthCare reported Q2 ...Full story available on Benzinga.com

Related tickers: TRHC.